Trellus Health Plc Stock Current Valuation
| TRLS Stock | 0.68 0.02 2.86% |
Valuation analysis of Trellus Health plc helps investors to measure Trellus Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Trellus Health's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 18.4 M in 2024, whereas Free Cash Flow is likely to drop (8 M) in 2024. Fundamental drivers impacting Trellus Health's valuation include:
Price Book 0.0879 | Enterprise Value -5.3 M | Enterprise Value Ebitda 1.0078 | Price Sales 19.8214 | Enterprise Value Revenue 19.8039 |
Overvalued
Today
Please note that Trellus Health's price fluctuation is out of control at this time. Calculation of the real value of Trellus Health plc is based on 3 months time horizon. Increasing Trellus Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Trellus stock is determined by what a typical buyer is willing to pay for full or partial control of Trellus Health plc. Since Trellus Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Trellus Stock. However, Trellus Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.68 | Real 0.65 | Hype 0.84 | Naive 0.61 |
The intrinsic value of Trellus Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Trellus Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Trellus Health plc helps investors to forecast how Trellus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Trellus Health more accurately as focusing exclusively on Trellus Health's fundamentals will not take into account other important factors: Trellus Health plc Company Current Valuation Analysis
Trellus Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Trellus Health Current Valuation | (5.3 M) |
Most of Trellus Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trellus Health plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Trellus Health plc has a Current Valuation of (5.3 Million). This is 100.04% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The current valuation for all United Kingdom stocks is 100.03% higher than that of the company.
Trellus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trellus Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trellus Health could also be used in its relative valuation, which is a method of valuing Trellus Health by comparing valuation metrics of similar companies.Trellus Health is currently under evaluation in current valuation category among its peers.
Trellus Fundamentals
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (81.08) % | ||||
| Current Valuation | (5.3 M) | ||||
| Shares Outstanding | 161.51 M | ||||
| Shares Owned By Insiders | 47.46 % | ||||
| Shares Owned By Institutions | 17.40 % | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 19.82 X | ||||
| Revenue | 19 K | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (5.85 M) | ||||
| Net Income | (6.8 M) | ||||
| Total Debt | 786 K | ||||
| Book Value Per Share | 0.1 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 0.24 | ||||
| Beta | 0.15 | ||||
| Market Capitalization | 1.09 M | ||||
| Total Asset | 20.29 M | ||||
| Retained Earnings | (21.81 M) | ||||
| Working Capital | 11.54 M | ||||
| Net Asset | 20.29 M |
About Trellus Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trellus Health plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trellus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trellus Health plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Trellus Stock Analysis
When running Trellus Health's price analysis, check to measure Trellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trellus Health is operating at the current time. Most of Trellus Health's value examination focuses on studying past and present price action to predict the probability of Trellus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trellus Health's price. Additionally, you may evaluate how the addition of Trellus Health to your portfolios can decrease your overall portfolio volatility.